Permira Funds and the Marcucci family complete investment in Kedrion & BPL
Announced appointment of Ugo Di Francesco as CEO
Results of the “Words in Hemophilia: Towards Patient Engagement” study have been published
The project supported by Kedrion defines some of the key principles intended to improve patient envolvement
Kedrion and LFB sign industrial cooperation agreement
Scope is supplying Immunoglobulins to meet patient demand in France
Kedrion announces the appointment of a new CEO
Val Romberg from the USA, one of the most esteemed managers in the industry
COVID-19. Kedrion partners with Columbia University Irving MC
Kedrion and Columbia University release video statements
Kedrion-Kamada collaboration for Anti Covid-19 IgG
The companies announced cooperation for developing Anti Covid-19 therapy
Letter to patient associations and scientific organizations
Communication from Paolo Marcucci, Chairman & CEO of Kedrion
Kedrion Statement on the novel Coronavirus
In accordance with international, national and local authority guidelines, Kedrion has acted immediately in dealing with the epidemiological emergency linked to the spread of the new Coronavirus (SARS-CoV-2), and has taken all necessary measures to safeguard the health and safety of its employees and guarantee continuation of business activities. Paolo Marcucci, Chairman & CEO has
Kedrion attends Italian embassy event in Budapest
The company strenghten the good relationship with local communities
Hemophilia seen through children’s eyes: Kedrion teams up with LA Kelley
Three books of the series My First Factor Creation are now available for free download